DNA-repair-driven cell death compels us to rethink cancer therapies
- PMID: 40751092
- DOI: 10.1038/s41580-025-00879-4
DNA-repair-driven cell death compels us to rethink cancer therapies
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
Shaping the future of youth-onset type 2 diabetes: a call to action.Trends Endocrinol Metab. 2025 Apr 4:S1043-2760(25)00048-7. doi: 10.1016/j.tem.2025.03.003. Online ahead of print. Trends Endocrinol Metab. 2025. PMID: 40187960 Review.
-
Homologous recombination is a primary pathway to repair DNA double-strand breaks generated during DNA rereplication.J Biol Chem. 2014 Oct 17;289(42):28910-23. doi: 10.1074/jbc.M114.576488. Epub 2014 Aug 26. J Biol Chem. 2014. PMID: 25160628 Free PMC article.
-
Engineering the next generation of brain scientists.Neuron. 2015 Apr 8;86(1):16-20. doi: 10.1016/j.neuron.2015.03.029. Neuron. 2015. PMID: 25856480 Review.
-
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States.J Med Econ. 2022 Jan-Dec;25(1):469-480. doi: 10.1080/13696998.2022.2043634. J Med Econ. 2022. PMID: 35184650
-
Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer.J Cancer Res Clin Oncol. 2017 Sep;143(9):1733-1744. doi: 10.1007/s00432-017-2427-1. Epub 2017 Apr 21. J Cancer Res Clin Oncol. 2017. PMID: 28432456 Free PMC article.
References
LinkOut - more resources
Full Text Sources